Home › Compare › PGXFF vs JNJ

PGXFF vs JNJ: Dividend Comparison 2026

PGXFF yields 6666.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PGXFF wins by $1028095347812062.00M in total portfolio value
10 years
PGXFF
PGXFF
● Live price
6666.67%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1028095347812062.00M
Annual income
$998,628,545,336,266,700,000.00
Full PGXFF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PGXFF vs JNJ

📍 PGXFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPGXFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PGXFF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PGXFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PGXFF
Annual income on $10K today (after 15% tax)
$566,666.67/yr
After 10yr DRIP, annual income (after tax)
$848,834,263,535,826,600,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, PGXFF beats the other by $848,834,263,535,826,600,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PGXFF + JNJ for your $10,000?

PGXFF: 50%JNJ: 50%
100% JNJ50/50100% PGXFF
Portfolio after 10yr
$514047673906031.00M
Annual income
$499,314,272,668,133,360,000.00/yr
Blended yield
97.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PGXFF
No analyst data
Altman Z
-31.2
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PGXFF buys
0
JNJ buys
0
No recent congressional trades found for PGXFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPGXFFJNJ
Forward yield6666.67% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$1028095347812062.00M ✓$20.0K
Annual income after 10y$998,628,545,336,266,700,000.00 ✓$827.78
Total dividends collected$1026118102492338.88M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PGXFF vs JNJ ($10,000, DRIP)

YearPGXFF PortfolioPGXFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$677,367$666,666.67$10,676$355.77+$666.7K → PGXFF
2$42,928,313$42,203,530.63$11,407$389.39+$42.92M → PGXFF
3$2,545,616,701$2,499,683,405.64$12,198$426.53+$2545.60M → PGXFF
4$141,255,910,403$138,532,100,533.89$13,056$467.62+$141255.90M → PGXFF
5$7,335,374,338,812$7,184,230,514,680.15$13,987$513.12+$7335374.32M → PGXFF
6$356,516,885,536,661$348,668,034,994,132.70$14,998$563.56+$356516885.52M → PGXFF
7$16,218,956,689,966,618$15,837,483,622,442,392.00$16,098$619.52+$16218956689.95M → PGXFF
8$690,711,023,145,868,900$673,356,739,487,604,600.00$17,295$681.69+$690711023145.85M → PGXFF
9$27,539,067,734,387,980,000$26,800,006,939,621,900,000.00$18,599$750.82+$27539067734387.96M → PGXFF
10$1,028,095,347,812,062,000,000$998,628,545,336,266,700,000.00$20,022$827.78+$1028095347812062.00M → PGXFF

PGXFF vs JNJ: Complete Analysis 2026

PGXFF — Stock

Prosper Gold Corp. engages in the acquisition, exploration, and development of mineral properties in Canada. It explores for copper and gold resources. The company's property portfolio includes the Star property in British Columbia, and the Ontario projects in Ontario. In addition, the company holds an option to acquire a 100% interest in the Golden Sidewalk and Skinner gold properties, consisting of approximately 16,000 hectares of mineral claims and leases located in the Red Lake mining district of Ontario. The company was formerly known as Lander Energy Corporation and changed its name to Prosper Gold Corp. in April 2012.Prosper Gold Corp. was incorporated in 2007 and is based in Vancouver, Canada.

Full PGXFF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PGXFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PGXFF vs SCHDPGXFF vs JEPIPGXFF vs OPGXFF vs KOPGXFF vs MAINPGXFF vs ABBVPGXFF vs MRKPGXFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.